Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Incyte Corporation (INCY) News - StockMarketCap

Stocks›Incyte Corporation☆

● At closeAs of Jul 2, 2026

Incyte Corporation

INCY✓

HealthcareBiotechnologyNASDAQ

$116.86+2.68%

$23.35BMarket cap

15.53xP/E ratio

2.56MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$116.86

$3.05 (+2.68%) · 24h

Key metrics

Market cap$23.35B+18.59%

Enterprise value$19.22B

Volume (24h)2.56M

P/E ratio (TTM)15.53x

P/S ratio (TTM)4.22x

Dividend yield0.00%

Shares outstanding199.78M

Trading range

Previous close$113.81

Day range$113.50 - $118.69

52-week range$66.83 - $115.56

Incyte Corporation (INCY) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news